Publications by authors named "Atsuko Wanibuchi"

Claim this Profile
P
Population estimation regarding the effects of cytochrome P450 2C19 and 3A5 polymorphisms on zonisamide clearance.
Yusuke Okada, Takayuki Seo, Takateru Ishitsu, Atsuko Wanibuchi, Nami Hashimoto

Ther Drug Monit· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting beta1-selective blocker, in a dose escalation regimen in healthy male volunteers.
Makoto Murakami, Hidetoshi Furuie, Kyoko Matsuguma, Atsuko Wanibuchi, Shinichi Kikawa

Drug Metab Pharmacokinet· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humans.
Kaoru Kobayashi, Jun Morita, Kan Chiba, Atsuko Wanibuchi, Miyuki Kimura

Pharmacogenetics· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a Japanese subject with lowered capacity of mephobarbital 4'-hydroxylation.
Jun Morita, Kaoru Kobayashi, Atsuko Wanibuchi, Miyuki Kimura, Shin Irie

Drug Metab Pharmacokinet· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis